Orthopediatrics’ (NASDAQ:KIDS) lock-up period will end on Tuesday, April 10th. Orthopediatrics had issued 4,000,000 shares in its public offering on October 12th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. After the expiration of Orthopediatrics’ lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
A number of equities research analysts have recently weighed in on the company. Zacks Investment Research lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Wednesday, March 14th. BidaskClub lowered Orthopediatrics from a “hold” rating to a “sell” rating in a research note on Tuesday, January 9th. Finally, BTIG Research reissued a “buy” rating and issued a $24.00 target price on shares of Orthopediatrics in a research note on Friday, January 5th. Two equities research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $23.67.
KIDS opened at $16.34 on Monday. The company has a market cap of $208.68 and a price-to-earnings ratio of -2.87. The company has a debt-to-equity ratio of 0.53, a current ratio of 7.35 and a quick ratio of 5.29. Orthopediatrics has a one year low of $14.00 and a one year high of $23.00.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. DF Dent & Co. Inc. bought a new position in Orthopediatrics during the 4th quarter valued at approximately $1,794,000. TIAA CREF Investment Management LLC bought a new position in Orthopediatrics during the 4th quarter valued at approximately $130,000. Teachers Advisors LLC bought a new position in Orthopediatrics during the 4th quarter valued at approximately $102,000. California State Teachers Retirement System bought a new position in Orthopediatrics during the 4th quarter valued at approximately $141,000. Finally, Deutsche Bank AG bought a new position in Orthopediatrics during the 4th quarter valued at approximately $196,000. 32.34% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Orthopediatrics Corp’s Lock-Up Period Will End Tomorrow (NASDAQ:KIDS)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/04/09/orthopediatrics-corps-lock-up-period-will-end-tomorrow-nasdaqkids.html.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.